Anti-neutrophil Cytoplasmic Antibody in Interstitial Lung Disease.

计划入组 80 人 · 首次发布于 2020 年 6 月 2 日

Automated Reading of Anti-neutrophil Cytoplasmic Autoantibodies, Indispensable Markers of Vasculitis

计划入组 2,000 人 · 首次发布于 2018 年 8 月 21 日

Study of NM8074 in Patients with Anti-Neutrophil Cytoplasmic Antibody (ANCA)-Associated Vasculitis (AAV)

计划入组 12 人 · 首次发布于 2024 年 1 月 26 日

neutrophil promotor (ProMetic)

neutrophil targeting peptides

Avacopan(Tavneos)

C₃₃H₃₅F₄N₃O₂

Novel Anti-Infective Technologies, LLC

AiCuris Anti-Infective Cures AG

Germany

AGENCE REGIONALE DE SANTE DE LA REUNION

Reunion

Adicet Bio's ADI-001 Receives FDA Clearance for Expanded Autoimmune Trial

Adicet Bio's ADI-001 Demonstrates Promising CAR T-Cell Activation in Autoimmune Diseases

Adicet Bio's ADI-001 Receives FDA Fast Track for Refractory SLE, Expands Autoimmune Pipeline